Lung transplantation with donation after circulatory determination of death donors and the impact of ex vivo lung perfusion

American Journal of Transplantation

Volumn 15, Issue 4, 2015, Pages 993-1002

  Machuca, T N ^a   Mercier, O ^a   Collaud, S ^a   Tikkanen, J ^a   Krueger, T ^a   Yeung, J C ^a   Chen, M ^a   Azad, S ^a   Singer, L ^a   Yasufuku, K ^a   De Perrot, M ^a   Pierre, A ^a   Waddell, T K ^a   Keshavjee, S ^a   Cypel, M ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

clinical research practice; donors and donation: donation after circulatory death (DCD); donors and donation: donor evaluation; lung transplantation pulmonology; organ perfusion and preservation; organ procurement and allocation

Indexed keywords

PROSTAGLANDIN E1;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ARTIFICIAL VENTILATION; BRONCHOSCOPY; CAUSE OF DEATH; CLINICAL PROTOCOL; CYSTIC FIBROSIS; DOMATION AFTER CIRCULATORY DETERMINATION OF DEATH; EMPHYSEMA; EX VIVO LUNG PERFUSION; FEMALE; FIBROSING ALVEOLITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; KAPLAN MEIER METHOD; LENGTH OF STAY; LUNG COMPLIANCE; LUNG EDEMA; LUNG PERFUSION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; ORGAN TRANSPLANTATION; PATIENT SELECTION; POSITIVE END EXPIRATORY PRESSURE; PRIMARY GRAFT DYSFUNCTION; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; PULMONARY VEIN; REOPERATION; RETROSPECTIVE STUDY; SCLERODERMA; STERNOTOMY; SURVIVAL RATE; THORAX RADIOGRAPHY; TREATMENT OUTCOME; CIRCULATION; DONOR; LUNG; MIDDLE AGED; PERFUSION; PROGNOSIS;

ADULT; BLOOD CIRCULATION; FEMALE; HUMANS; LUNG; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PERFUSION; PROGNOSIS; RETROSPECTIVE STUDIES; TISSUE DONORS;

EID: 84925263902     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13124     Document Type: Article

References (44)

1. Egan TM, Lambert CJ Jr, Reddick R, et al. A strategy to increase the donor pool: Use of cadaver lungs for transplantation. Ann Thorac Surg 1991; 52: 1113-1120; discussion 1120-1111.
2. Ulicny KS Jr, Egan TM, Lambert CJ Jr, et al. Cadaver lung donors: Effect of preharvest ventilation on graft function. Ann Thorac Surg 1993; 55: 1185-1191.
3. D'Armini AM, Roberts CS, Griffith PK, et al. When does the lung die? I. Histochemical evidence of pulmonary viability after "death ". J Heart Lung Transplant 1994; 13: 741-747.
4. D'Alessandro AM, Hoffmann RM, Knechtle SJ, et al. Controlled non-heart-beating donors: A potential source of extrarenal organs. Transplant Proc 1995; 27: 707-709.
5. Mason DP, Murthy SC, Gonzalez-Stawinski GV, et al. Early experience with lung transplantation using donors after cardiac death. J Heart Lung Transplant 2008; 27: 561-563.
6. Yusen RD, Christie JD, Edwards LB, et al. The registry of the international society for heart and lung transplantation: Thirtieth adult lung and heart-lung transplant report-2013; focus theme: Age. J Heart Lung Transplant 2013; 32: 965-978.
7. Valapour M, Skeans MA, Heubner BM, et al. Optn/srtr 2012 annual data report: Lung. Am J Transplant 2014; 14 (Suppl 1) 139-165.
8. Titman A, Rogers CA, Bonser RS, et al. Disease-specific survival benefit of lung transplantation in adults: A national cohort study. Am J Transplant 2009; 9: 1640-1649.
9. Mason DP, Brown CR, Murthy SC, et al. Growing single-center experience with lung transplantation using donation after cardiac death. Ann Thorac Surg 2012; 94: 406-411; discussion 411-402.
10. Levvey BJ, Harkess M, Hopkins P, et al. Excellent clinical outcomes from a national donation-after-determination-of-cardiac-death lung transplant collaborative. Am J Transplant 2012; 12: 2406-2413.
11. Israni AK, Zaun D, Rosendale JD, et al. Optn/srtr 2012 annual data report: Deceased organ donation. Am J Transplant 2014; 14 (Suppl 1) 167-183.
12. Matas AJ, Smith JM, Skeans MA, et al. Optn/srtr 2012 annual data report: Kidney. Am J Transplant 2014; 14 (Suppl 1) 11-44.
13. Machuca TN, Cypel M, Keshavjee S., Advances in lung preservation. Surg Clin North Am 2013; 93: 1373-1394.
14. Steen S, Sjoberg T, Pierre L, et al. Transplantation of lungs from a non-heart-beating donor. Lancet 2001; 357: 825-829.
15. Cypel M, Yeung JC, Hirayama S, et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant 2008; 27: 1319-1325.
16. Cypel M, Yeung JC, Liu M, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 2011; 364: 1431-1440.
17. Cypel M, Yeung JC, Machuca T, et al. Experience with the first 50 ex vivo lung perfusions in clinical transplantation. J Thorac Cardiovasc Surg 2012; 144: 1200-1206.
18. de Perrot M, Chaparro C, McRae K, et al. Twenty-year experience of lung transplantation at a single center: Influence of recipient diagnosis on long-term survival. J Thorac Cardiovasc Surg 2004; 127: 1493-1501.
19. Fuehner T, Kuehn C, Hadem J, et al. Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med 2012; 185: 763-768.
20. Lang G, Taghavi S, Aigner C, et al. Primary lung transplantation after bridge with extracorporeal membrane oxygenation: A plea for a shift in our paradigms for indications. Transplantation 2012; 93: 729-736.
21. Christie JD, Carby M, Bag R, et al. Report of the ishlt working group on primary lung graft dysfunction part ii: Definition. A consensus statement of the international society for heart and lung transplantation. J Heart Lung Transplant 2005; 24: 1454-1459.
22. Oto T, Levvey BJ, Whitford H, et al. Feasibility and utility of a lung donor score: Correlation with early post-transplant outcomes. Ann Thorac Surg 2007; 83: 257-263.
23. Zych B, Popov AF, Amrani M, et al. Lungs from donation after circulatory death donors: An alternative source to brain-dead donors? Midterm results at a single institution. Eur J Cardiothorac Surg 2012; 42: 542-549.
24. De Vleeschauwer SI, Wauters S, Dupont LJ, et al. Medium-term outcome after lung transplantation is comparable between brain-dead and cardiac-dead donors. J Heart Lung Transplant 2011; 30: 975-981.
25. Van De Wauwer C, Verschuuren EA, van der Bij W, et al. The use of non-heart-beating lung donors category iii can increase the donor pool. Eur J Cardiothorac Surg 2011; 39: e175-180; discussion e180.
26. Yeung JC, Cypel M, Machuca TN, et al. Physiologic assessment of the ex vivo donor lung for transplantation. J Heart Lung Transplant 2012; 31: 1120-1126.
27. Kuang JQ, Van Raemdonck DE, Jannis NC, et al. Pulmonary cell death in warm ischemic rabbit lung is related to the alveolar oxygen reserve. J Heart Lung Transplant 1998; 17: 406-414.
28. Miyoshi K, Oto T, Otani S, et al. Effect of donor pre-mortem hypoxia and hypotension on graft function and start of warm ischemia in donation after cardiac death lung transplantation. J Heart Lung Transplant 2011; 30: 445-451.
29. Tremblay LN, Yamashiro T, DeCampos KN, et al. Effect of hypotension preceding death on the function of lungs from donors with nonbeating hearts. J Heart Lung Transplant 1996; 15: 260-268.
30. Bregeon F, Papazian L, Delpierre S, et al. Role of proinflammatory activity contained in gastric juice from intensive care unit patients to induce lung injury in a rabbit aspiration model. Crit Care Med 2008; 36: 3205-3212.
31. Raghavendran K, Nemzek J, Napolitano LM, et al. Aspiration-induced lung injury. Crit Care Med 2011; 39: 818-826.
32. Sanchez PG, Bittle GJ, Williams K, et al. Ex vivo lung evaluation of prearrest heparinization in donation after cardiac death. Ann Surg 2013; 257: 534-541.
33. Machuca TN, Hsin MK, Ott HC, et al. Injury-specific ex vivo treatment of the donor lung: Pulmonary thrombolysis followed by successful lung transplantation. Am J Respir Crit Care Med 2013; 188: 878-880.
34. Dong B, Stewart PW, Egan TM., Postmortem and ex vivo carbon monoxide ventilation reduces injury in rat lungs transplanted from non-heart-beating donors. J Thorac Cardiovasc Surg 2013; 146: 429-436 e421.
35. Inci I, Zhai W, Arni S, et al. Fibrinolytic treatment improves the quality of lungs retrieved from non-heart-beating donors. J Heart Lung Transplant 2007; 26: 1054-1060.
36. Mulloy DP, Stone ML, Crosby IK, et al. Ex vivo rehabilitation of non-heart-beating donor lungs in preclinical porcine model: Delayed perfusion results in superior lung function. J Thorac Cardiovasc Surg 2012; 144: 1208-1215.
37. Nakajima D, Chen F, Yamada T, et al. Reconditioning of lungs donated after circulatory death with normothermic ex vivo lung perfusion. J Heart Lung Transplant 2012; 31: 187-193.
38. Diamond JM, Lee JC, Kawut SM, et al. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 2013; 187: 527-534.
39. Anraku M, Cameron MJ, Waddell TK, et al. Impact of human donor lung gene expression profiles on survival after lung transplantation: A case-control study. Am J Transplant 2008; 8: 2140-2148.
40. Kaneda H, Waddell TK, de Perrot M, et al. Pre-implantation multiple cytokine mrna expression analysis of donor lung grafts predicts survival after lung transplantation in humans. Am J Transplant 2006; 6: 544-551.
41. Kang CH, Anraku M, Cypel M, et al. Transcriptional signatures in donor lungs from donation after cardiac death vs after brain death: A functional pathway analysis. J Heart Lung Transplant 2011; 30: 289-298.
42. Machuca TN, Cypel M, Yeung JC, et al. Protein expression profiling predicts graft performance in clinical ex vivo lung perfusion. Ann Surg 2014; in press.
43. Machuca TN, Cypel M, Zhao Y, et al. Endothelin-1 and big-endothelin-1 as potential biomarkers in clinical ex vivo lung perfusion. J Heart and Lung Transplant 2013; 32: S67.
44. Cypel M, Sato M, Yildirim E, et al. Initial experience with lung donation after cardiocirculatory death in Canada. J Heart Lung Transplant 2009; 28: 753-758.